This is a working overview of GHRH receptor, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-18. Anything still debated is marked as such rather than presented as settled.
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | G-protein-coupled receptor on pituitary somatotrophs |
| Half-life, long-acting form | Several days | Extended by covalent albumin binding |
| Half-life, short form | About 30 minutes | Cleared rapidly by peptidases and kidneys |
| Route in studies | Subcutaneous injection | Used in the published human trials |
| Main measured effect | Rise in GH and IGF-1 | Surrogate markers rather than clinical endpoints |
Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.
Once in circulation, the peptide binds the growth hormone-releasing hormone receptor displayed on pituitary somatotroph cells. Receptor activation couples to Gs proteins, elevates intracellular cyclic AMP, and drives protein kinase A signaling inside the cell. That cascade increases discharge of growth hormone into the bloodstream. The analog therefore operates through a receptor pathway that already exists for the body's own releasing hormone, rather than through an engineered artificial target.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
== Further reading == Ghelardini, C.; Galeotti, N.; Di Cesare Mannelli, L.; Mazzanti, G.; Bartolini, A. (2001). "Local anaesthetic activity of beta-caryophyllene". Farmaco. 56 (5–7): 387–389. doi:10.1016/S0014-827X(01)01092-8. hdl:2158/397975. PMID 11482764.
Historically an agrarian economy, Colombia urbanized rapidly in the 20th century, by the end of which just 15.8% of the workforce were employed in agriculture, generating just 6.6% of GDP; 20% of the workforce were employed in industry and 65% in services, responsible for 33% and 60% of GDP respectively. The country's economic production is dominated by its strong domestic demand. Consumption expenditure by households is the largest component of GDP. Colombia's market economy grew steadily in the latter part of the 20th century, with gross domestic product (GDP) increasing at an average rate of over 4% per year between 1970 and 1998. The country suffered a recession in 1999 (the first full year of negative growth since the Great Depression), and the recovery was long and painful. However, growth reaching 7% in 2007, one of the highest in Latin America. According to International Monetary Fund estimates, in 2023, Colombia's GDP (PPP) was US$1 trillion, 32nd in the world and third in South America, after Brazil and Argentina. Total government expenditures account for 28% of the domestic economy. External debt equals 40% of gross domestic product. A strong fiscal climate was reaffirmed by a boost in bond ratings. Annual inflation closed 2017 at 4.09% YoY (vs. 5.75% YoY in 2016). The average national unemployment rate in 2017 was 9.4%, although the informality is the biggest problem facing the labour market (the income of formal workers climbed 24.8% in 5 years while labor incomes of informal workers rose only 9%).
=== Lycopene === Lycopene is a key intermediate in the biosynthesis of beta-carotene and xanthophylls. Lycopene may be the most powerful carotenoid quencher of singlet oxygen. Due to its strong color and non-toxicity, lycopene is a useful food coloring (registered as E160d) and is approved for usage in the US, Australia and New Zealand (registered as 160d) and the EU.
=== 1999–2003: The Double Duo, The ConstruKction of Light and The Power to Believe === King Crimson reconvened in 1999. With Levin busy with session work, and believing Bruford to be more concerned with his jazz band Earthworks than Crimson, Fripp decided the next phase of King Crimson would be a "Double Duo" of himself, Belew, Gunn, and Mastelotto. This line-up recorded The ConstruKction of Light at Belew's home studio in Mount Juliet, Tennessee. Fripp was inspired by Tool's album Undertow during the writing process of The ConstruKction of Light. Released in May 2000, the album reached No. 129 in the UK. Most of the pieces were metallic, harsh and industrial metal–influenced, featuring Mastelotto performing exclusively on electronic drums, Gunn taking over the bass role on Warr Guitar, and a different take on the interlocking guitars of the 1980s quartet. With the exception of an "industrial blues" sung by Belew through a voice changer (under the pseudonym of "Hooter J. Johnson"), the songs were dense and complex. The album also contained the fourth installment of "Larks' Tongues in Aspic". It received a negative reception for lacking new ideas. At the same time as recording The ConstruKction of Light, the band also recorded an album of improvised instrumentals, Heaven and Earth, released under the name ProjeKct X.
Sources: en.wikipedia.org
=== Respiratory === The primary cause of respiratory failure in dermatomyositis is interstitial lung disease, resulting from damage to the lung interstitium. This is particularly prominent in patients with anti–MDA5 autoantibodies, who are at high risk of developing rapidly progressive interstitial lung disease. In some people, the condition affects the diaphragm muscle, the lungs directly (through inflammation), or both. This causes difficulty breathing, and dermatomyositis is considered to be a restrictive lung disease in patients with these symptoms. Respiratory symptoms occur in about 40% of people with dermatomyositis, and in these people, the symptoms may slowly progress, contributing to increased morbidity and mortality.
Trials are investigating whether botulinum toxin, when used to make a person appear to frown less, stops negative feedback from the face and affects depression. Psilocybin may have a beneficial role in the treatment of depression. A 2019 meta-analysis found that hypnotherapy may be an effective way of alleviating the symptoms of depression. No model of depression in animals that fully explains the mechanism of depression has been found as of 2019.
In contemporary Western use, turquoise is most often encountered cut en cabochon in silver rings, bracelets, often in the Native American style, or as tumbled or roughly hewn beads in chunky necklaces. Lesser material may be carved into fetishes, such as those crafted by the Zuni. While strong sky blues remain superior in value, mottled green and yellowish material is popular with artisans.
Compounds containing one or more elements which can exist in a variety of charge/oxidation states will have a stoichiometry that depends on which oxidation states are present, to ensure overall neutrality. This can be indicated in the name by specifying either the oxidation state of the elements present, or the charge on the ions. Because of the risk of ambiguity in allocating oxidation states, IUPAC prefers direct indication of the ionic charge numbers. These are written as an arabic integer followed by the sign (... , 2−, 1−, 1+, 2+, ...) in parentheses directly after the name of the cation (without a space separating them). For example, FeSO4 is named iron(2+) sulfate (with the 2+ charge on the Fe2+ ions balancing the 2− charge on the sulfate ion), whereas Fe2(SO4)3 is named iron(3+) sulfate (because the two iron ions in each formula unit each have a charge of 3+, to balance the 2− on each of the three sulfate ions). Stock nomenclature, still in common use, writes the oxidation number in Roman numerals (... , −II, −I, 0, I, II, ...). So the examples given above would be named iron(II) sulfate and iron(III) sulfate respectively. For simple ions the ionic charge and the oxidation number are identical, but for polyatomic ions they often differ. For example, the uranyl(2+) ion, UO2+2, has uranium in an oxidation state of +6, so would be called a dioxouranium(VI) ion in Stock nomenclature.
== Naming conventions == Before reunification, Germany was divided between the Bundesrepublik Deutschland (Federal Republic of Germany; commonly known as West Germany) and the Deutsche Demokratische Republik (DDR; German Democratic Republic; commonly known as East Germany). Reunification was achieved by accession (Beitritt) of the German Democratic Republic to the Federal Republic of Germany, so Bundesrepublik Deutschland became the official name of reunified Germany. In East Germany, the terms Westdeutschland (West Germany) or westdeutsche Bundesrepublik (West German Federal Republic) were preferred during the 1950s and 1960s. This changed under its constitutional amendment in 1974, when the idea of a single German nation was abandoned by East Germany. As a result, it officially considered West Germans and West Berliners as foreigners. The initialism BRD (FRG in English) began to prevail in East German usage in the early 1970s, beginning in the newspaper Neues Deutschland. Other Eastern Bloc nations soon followed suit. In 1965, the West German Federal Minister of All-German Affairs, Erich Mende, had issued the "Directives for the Appellation of Germany", recommending avoiding the initialism BRD. On 31 May 1974, the heads of West German federal and state governments recommended always using the full name in official publications. From then on, West German sources avoided the abbreviated form, with the exception of left-leaning organisations which embraced it.
Sources: en.wikipedia.org
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.
The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.
Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.
Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.